A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo

PHASE3RecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2026

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Jitongning tablets

The participants took orally three tablets of Jitongning tablets, twice a day, for 8 consecutive weeks.

DRUG

a simulated agent of Jitongning tablets

The participants took orally three tablets of a simulated agent of Jitongning tablets, twice a day, for 8 consecutive weeks.

Trial Locations (10)

100078

RECRUITING

Dongfang Hospital, Beijing University of Chinese Medicine, Beijing

Unknown

RECRUITING

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

RECRUITING

The First Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

RECRUITING

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Suzhou Hospital of Traditional Chinese Medicine, Suzhou

RECRUITING

Affiliated Hospital of North Sichuan Medical College, Nanchong

RECRUITING

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

RECRUITING

Yunnan Province Hospital of Traditional Chinese Medicine, Kunming

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY